i_need_contribute
|
Country, |
Total |
New |
Total |
|
World |
223,382,127 |
+599,983 |
4,608,911 |
|
41,397,587 |
+157,759 |
671,183 |
|
|
33,138,856 |
+43,406 |
441,782 |
|
|
20,928,008 |
+14,430 |
584,458 |
|
|
7,094,592 |
+38,975 |
133,674 |
|
|
7,065,904 |
+18,024 |
189,582 |
|
|
6,866,856 |
+12,828 |
115,259 |
|
|
6,566,568 |
+23,914 |
58,913 |
|
|
5,215,332 |
+3,531 |
112,962 |
|
|
5,210,978 |
+26,854 |
112,430 |
|
|
4,923,197 |
+1,787 |
125,427 |
|
|
4,898,258 |
+5,618 |
85,147 |
|
|
4,585,423 |
+5,923 |
129,707 |
|
|
4,147,365 |
+6,731 |
137,782 |
|
|
4,044,712 |
+14,863 |
92,988 |
|
|
3,449,295 |
+15,784 |
264,541 |
|
|
2,891,602 |
+533 |
75,403 |
|
|
2,836,773 |
+7,338 |
84,152 |
|
|
2,303,276 |
+2,772 |
54,114 |
|
|
2,157,536 |
+1,085 |
198,595 |
|
|
2,134,005 |
+12,751 |
34,672 |
|
|
1,961,585 |
+2,781 |
18,055 |
|
|
1,934,335 |
+5,405 |
21,282 |
|
|
1,900,467 |
+19,733 |
19,163 |
|
|
1,681,681 |
+588 |
30,408 |
|
|
1,642,146 |
+355 |
37,122 |
|
|
1,590,994 |
+10,603 |
16,436 |
|
|
1,529,300 |
+3,654 |
27,106 |
|
|
1,522,302 |
+2,497 |
26,736 |
|
|
1,322,519 |
+14,176 |
13,511 |
|
|
1,198,503 |
+1,847 |
25,428 |
|
|
1,190,136 |
+3,902 |
26,413 |
|
|
1,139,887 |
+2,637 |
7,261 |
|
|
1,111,155 |
+2,079 |
34,792 |
|
|
1,050,719 |
+1,778 |
17,826 |
|
|
893,462 |
+3,930 |
13,296 |
|
|
824,118 |
+3,639 |
9,987 |
|
|
814,064 |
+246 |
30,077 |
|
|
804,326 |
+975 |
10,501 |
|
|
794,528 |
+5,633 |
7,445 |
|
|
773,529 |
+1,347 |
10,889 |
|
|
726,025 |
+833 |
2,053 |
|
|
712,992 |
+8,317 |
5,967 |
|
|
701,216 |
+2,268 |
10,815 |
|
|
678,363 |
+2,592 |
23,993 |
|
|
610,197 |
+1,008 |
8,144 |
|
|
607,356 |
+2,198 |
14,014 |
|
|
570,493 |
+2,571 |
7,977 |
|
|
563,676 |
+12,680 |
14,135 |
|
|
545,624 |
+119 |
8,598 |
|
|
497,690 |
+5,120 |
12,468 |
|
|
495,578 |
+1,760 |
3,871 |
|
|
493,518 |
+403 |
18,529 |
|
|
483,984 |
+2,884 |
5,702 |
|
|
474,780 |
+2,917 |
10,689 |
|
|
466,671 |
+1,956 |
19,335 |
|
|
460,829 |
+330 |
7,104 |
|
|
459,062 |
+85 |
16,020 |
|
|
450,282 |
+2,557 |
5,959 |
|
|
423,104 |
+2,702 |
16,173 |
|
|
410,562 |
+66 |
2,427 |
|
|
396,904 |
+417 |
12,553 |
|
|
386,082 |
+156 |
6,037 |
|
|
379,963 |
+1,237 |
8,395 |
|
|
361,881 |
+2,645 |
3,769 |
|
|
360,957 |
+1,537 |
5,155 |
|
|
350,405 |
+514 |
2,599 |
|
|
347,511 |
+1,377 |
9,179 |
|
|
343,178 |
+1,030 |
4,150 |
|
|
319,568 |
+1,499 |
4,374 |
|
|
319,101 |
+1,529 |
4,830 |
|
|
304,600 |
+854 |
4,630 |
|
|
302,867 |
+52 |
4,083 |
|
|
291,172 |
+399 |
16,824 |
|
|
273,366 |
+114 |
1,388 |
|
|
272,512 |
+1,093 |
4,461 |
|
|
272,325 |
+790 |
6,466 |
|
|
265,423 |
+2,049 |
2,334 |
|
|
246,410 |
+645 |
4,954 |
|
|
243,719 |
+3,677 |
982 |
|
|
241,783 |
+649 |
4,830 |
|
|
234,093 |
+165 |
604 |
|
|
207,442 |
+148 |
3,622 |
|
|
198,962 |
+317 |
5,489 |
|
|
197,046 |
+559 |
2,578 |
|
|
181,620 |
+701 |
6,153 |
|
|
176,779 |
+97 |
2,561 |
|
|
171,719 |
+1,546 |
826 |
|
|
161,768 |
+660 |
1,132 |
|
|
153,840 |
+104 |
7,157 |
|
|
153,318 |
+1,079 |
2,528 |
|
|
148,552 |
+108 |
1,888 |
|
|
145,402 |
+459 |
2,595 |
|
|
144,878 |
+488 |
1,305 |
|
|
131,686 |
+632 |
1,039 |
|
|
125,931 |
+135 |
4,517 |
|
|
125,897 |
+125 |
3,417 |
|
|
122,543 |
+386 |
1,084 |
|
|
120,847 |
+133 |
3,068 |
|
|
119,602 |
+533 |
1,780 |
|
|
115,657 |
+182 |
523 |
|
|
31,894 |
+502 |
746 |
|
|
14,955 |
+42 |
153 |
Retrieved from: https://www.worldometers.info/coronavirus/
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo
The U.S. Food and Drug Administration declined Humanigen Inc's (HGEN.O) request for emergency use authorization of its lenzilumab drug to treat newly hospitalized COVID-19 patients, the company said on Thursday.
"In its letter, FDA stated that it was unable to conclude that the known and potential benefits of lenzilumab outweigh the known and potential risks of its use as a treatment for COVID-19," the company said in a statement.
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-emergency-use-approval-humanigens-covid-19-drug-2021-09-09/
A medical worker holds a bottle of AstraZeneca's COVID-19 vaccine at a vaccination centre in Kuala Lumpur, Malaysia May 5, 2021 in this file photo. REUTERS/Lim Huey Teng/File Photo/File Photo
Europe's medicines regulator has added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome, as a possible side-effect of AstraZeneca's (AZN.L) COVID-19 vaccine, regular safety updates from the watchdog showed on Wednesday.
The European Medicines Agency said a causal relationship between GBS and the AstraZeneca shot, known as Vaxzevria, was a "at least a reasonable possibility" after 833 cases of GBS were reported out of 592 million doses of the vaccine given worldwide by July 31.
The EMA categorised the side-effect as "very rare", the lowest frequency of side-effect category it has, and has emphasised that the benefits of the shot outweigh the risks.
The U.S. Food and Drug Administration has added a warning over Guillain-Barré syndrome as a possible side-effect of Johnson & Johnson's (JNJ.N) shot. Both vaccines use viral vector technology, and have also been associated with rare blood clots. read more
The EMA also tagged some other less severe side-effects to vaccines from Johnson & Johnson (JNJ.N), Moderna as well as AstraZeneca's shot.
https://www.reuters.com/business/healthcare-pharmaceuticals/eu-lists-rare-nerve-disorder-possible-side-effect-astrazeneca-covid-19-vaccine-2021-09-08/
Vaccine developer Novavax Inc (NVAX.O) said on Wednesday it has initiated an early-stage study to test its combined flu and COVID-19 vaccine.
The trial, to be conducted in Australia, will enroll 640 healthy adults between the ages of 50 and 70 years and who have either been previously infected with the coronavirus or given an authorized COVID-19 vaccine at least eight weeks prior to the study.
Participants will receive a combination of the company's COVID-19 vaccine candidate, NVX-CoV2373, and its Influenza shot NanoFlu along with an adjuvant or vaccine booster.
"Combination of these two vaccines...may lead to greater efficiencies for the healthcare system and achieve high levels of protection against COVID-19 and influenza with a single regimen," Gregory Glenn, President of Research and Development at Novavax, said in a statement.
Novavax had said in May it expects seasonal influenza and COVID-19 combination vaccines to likely be critical in combating emerging COVID-19 variants. Its vaccine NanoFlu/NVX-CoV2373 had elicited robust responses to both influenza A and B and protected against the coronavirus in pre-clinical studies. read more
Novavax expects the trial results in the first half of 2022.
https://www.reuters.com/business/healthcare-pharmaceuticals/novavax-begins-early-stage-trial-combined-influenzacovid-19-vaccine-2021-09-08/
By Daniel Politi
A pregnant woman receiving a dose of Covid vaccine in Havana last month.Credit...Ramon Espinosa/Associated Press
The coronavirus pandemic could “wipe away 20 years of hard-fought gains” in reducing maternal mortality in Latin America and the Caribbean, and countries in the region should prioritize those who are pregnant and those who have recently given birth in their vaccination campaigns, officials at the World Health Organization warned on Wednesday.
“So far, more than 270,000 pregnant women have become sick with Covid in the Americas and more than 2,600 of them — or 1 percent of those infected — have died from the virus,” Dr. Carissa F. Etienne, the director of the Pan American Health Organization, a division of the W.H.O., said at a news conference.
Pregnancy enhances vulnerability to respiratory infections, including Covid-19, and is associated with a higher likelihood of serious Covid symptoms.
Most countries have reported higher numbers of cases and deaths during pregnancy in 2021 than in all of last year, and in Mexico and Colombia Covid-19 has become the top cause of maternal death this year. Mexico, Argentina and Brazil have accounted for half of all maternal Covid-19 deaths in the Americas, Dr. Etienne said.
Her organization recommends that vaccinations be universal during the first trimester of pregnancy and for those who are breastfeeding, as breast milk confers the vaccine’s protection to newborns. That is guidance similar to that issued last month by the Centers for Disease Control and Prevention.
However, less than half of the countries in Latin America and the Caribbean have set out specific vaccination guidelines related to pregnancy and birth, Dr. Etienne said.
In Mexico which has prioritized shots during pregnancy for some time, Dr. Etienne said, “not a single vaccinated woman has died from Covid during pregnancy.”
However, the pandemic has decreased access to prenatal care, Dr. Etienne said, noting that at least 40 percent of the countries in Latin America and the Caribbean have reported disruptions to maternal and newborn care. And the region continues to suffer from a general shortage of vaccines. Only 28 percent of people in Latin America and the Caribbean have been fully inoculated against Covid-19, Dr. Etienne said.
In some countries in the region, the numbers are far lower, with one-quarter of them vaccinating less than 20 percent of their population. Venezuela has fully vaccinated a little more than 11 percent of its population; Guatemala and Nicaragua have fully vaccinated less than 10 percent of their people; and in Haiti, the percentage falls to less than 1 percent.
In the Caribbean, infections are dropping as a whole, although there is an increase in Covid-19 deaths in several islands, including Jamaica and Puerto Rico.
Infections are also rising in several Central American countries, including Costa Rica, Belize, and Guatemala, where half of hospitals are over capacity.
By contrast, in South America, with the exception of Venezuela, cases and deaths have been steadily dropping. Officials with the Pan American Health Organization did not address if testing volume in the region may have affected the number of reported cases.
“We are working jointly with the ministries of health and experts in the counties to study trends and the reasons as to why these decreases have continued,” said Ciro Ugarte, the organization’s director of health emergencies. “When cases decrease it’s because we are doing things well, which means we’re implementing the public health measures that have proven once and again that they still work.”
Now though, countries in the region need to be careful not to relax those measures, he said, “because that is a great opportunity for the virus.”
Retrieved from: https://www.nytimes.com/2021/09/08/world/americas/covid-pregnancy-caribbean-latin-america.html
Parents in Mexico are fighting a government program that restricts vaccination to people over the age of 18, though regulators have approved shots for use in children as young as 12.Credit...Joebeth Terriquez/EPA, via Shutterstock
Hundreds of parents in Mexico are asking for court injunctions to have their children vaccinated against Covid-19 before they return to school, because the government is yet to offer a shot to people ages 12 to 18 even though they are authorized to receive it.
The legal battle is taking place as the more transmissible Delta variant has pummeled Mexico, where only 28 percent of the population is fully vaccinated. The country is recording some of its highest daily caseloads of the pandemic, according to data compiled by the Center for Systems Science and Engineering at Johns Hopkins University.
President Andrés Manuel López Obrador’s administration wants all students to return to school for in-person classes, which have been suspended for almost a year and a half. The Pfizer vaccine was approved in Mexico for use in children age 12 and above in June, but so far only those age 18 and above have been able to get shots.
In the United States and various Latin American countries, vaccinations for children age 12 and above are well underway. But Mexican officials have downplayed the risk of the virus for minors, saying older people still waiting for their doses should be given priority.
Alma Franco, a lawyer from the southern region of Oaxaca, was one of the first parents to sue and win an injunction. When she was granted the vaccine for her 12-year-old son, she tweeted a photo of the constitutional appeal, or “amparo,” a legal process used in Mexico. In her appeal arguing that her son should be entitled to vaccination, Ms. Franco cited both the Health Department’s approval for the Pfizer vaccine and Mexico’s laws around equal medical care.
Since then, she said, about 1,000 parents from around the country have emailed her asking how they can do the same.
“Most of the parents who have asked me for the amparo are just worried about what’s happening at a global level, and particularly in Mexico,” Ms. Franco said.
Hugo López-Gatell Ramírez, the deputy health minister who is running Mexico’s response to the coronavirus, said at a news conference on Tuesday that 262 legal appeals have been filed by parents since August, with the number rapidly increasing. He said that although he understood why parents want to ensure their children are vaccinated, every dose given to a student because of judicial action would otherwise have gone to someone with a higher risk of dying from Covid-19.
“Scientific evidence is abundantly clear and consistent that those who have the highest risk of severe Covid, hospitalization, intubation and death are older people,” Mr. López-Gatell said. “There is a scale where the risk is progressively decreasing for younger ages.”
The new school year in Mexico began on Aug. 30, and the Mexican department of public education released a statement on Tuesday saying that 12 million students 18 and under were attending classes in over 135,000 schools. Entering the second week of the academic year, 88 schools have had coronavirus cases, and 39 had closed “as a preventive measure,” Delfina Gómez Álvarez, the secretary of education, said in the statement.
Retrieved from: https://www.nytimes.com/live/2021/09/08/world/covid-delta-variant-vaccine/parents-in-mexico-turn-to-courts-to-get-their-children-vaccinated
Here are the key developments from the last few hours:
· The UK health secretary, Sajid Javid, asked about the possibility of a so-called “October firebreak” in England, said: “I haven’t even thought about that as an option at this point.”
· Javid also backed 12- to 15-year-olds being able to take Covid vaccines against the wishes of their parents, and said that he was ‘confident’ that a booster jab programme will start this month in the UK.
· In the UK, vaccines minister Nadhim Zahawi has defended the planned introduction of Covid vaccine passports, telling MPs “this approach is designed to reduce transmission and serious illness”.
· Data shows that road traffic in the UK was at 100% of pre-crisis levels on Monday. Demand for buses also reached the highest level for a weekday since March 2020.
· The Covax vaccine-sharing initiative is set to receive 575m fewer anti-Covid shots this year than previously estimated, the Global Alliance for Vaccines and Immunisation (Gavi) has warned.
· Lothar Wieler, the head of the Robert Koch Institute for infectious disease in Germany, has said that the country could see a “massive momentum” in new Covid cases in autumn if the vaccination rate does not increase.
· The Czech Republic on Wednesday recorded 588 new cases of coronavirus, the highest daily tally since 25 May, as government officials predict a continued rise in infections.
· People will need to show a Covid-status certificate to enter bars, restaurants and fitness centres in Switzerland from Monday, the government ordered
· The city of Brussels is expected to introduce a Covid vaccine pass from 1 October, requiring residents to prove their health status to enter bars, restaurants and other public places.
Medicine
